Skip to menu Skip to content Skip to footer

2007

Conference Publication

Live donor characteristics over the last 15 years

Kaisar, M. O., Campbell, S., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Isbel, N. (2007). Live donor characteristics over the last 15 years. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Live donor characteristics over the last 15 years

2007

Conference Publication

Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers

Rajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers. 46th ASMR National Scientific Conference, Katoomba, N.S.W., Australia, 11-13 November 2007.

Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers

2007

Conference Publication

The molecular and cellular changes associated with ageing and disease in the kidney

Percy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2007). The molecular and cellular changes associated with ageing and disease in the kidney. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8-12 September, 2007.

The molecular and cellular changes associated with ageing and disease in the kidney

2007

Journal Article

The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation

Hourigan, M. J., Mollee, P. N., Gill, D. S., Doecke, J., Norris, D., Johnson, D. W. and Gandhi, M. K.. (2007). The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation. American Journal of Transplantation, 7, 399-399.

The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation

2007

Conference Publication

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia:

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

2007

Conference Publication

Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient

Kaisar, M. O., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2007). Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient

2007

Journal Article

Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors

Orazio, Linda, Armstrong, Kirsty, Banks, Merrilyn, Johnson, David, Isbel, Nikky and Hickman, Ingrid (2007). Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors. Nutrition & Dietetics, 64 (3), 200-206. doi: 10.1111/j.1747-0080.2007.00151.x

Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors

2007

Journal Article

Evaluation of renal function: CARI guidelines

Johnson, David W. (2007). Evaluation of renal function: CARI guidelines. Australian Family Physician, 36 (1-2), 46-46.

Evaluation of renal function: CARI guidelines

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Conference Publication

Intravenous versus oral iron supplementation in peritoneal dialysis patients

Johnson, David W. (2007). Intravenous versus oral iron supplementation in peritoneal dialysis patients. The 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25-29 August, 2006. Milton, Ontario: Multimed Inc..

Intravenous versus oral iron supplementation in peritoneal dialysis patients

2007

Journal Article

Update for GPs on the management of mild to moderate renal impairment.

Mathew, T. and Johnson, D. (2007). Update for GPs on the management of mild to moderate renal impairment.. Medical Observer, 31-34.

Update for GPs on the management of mild to moderate renal impairment.

2006

Journal Article

Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines

Morais, Christudas, Pat, Betty, Gobe, Glenda, Johnson, David W. and Healy, Helen (2006). Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrology Dialysis Transplantation, 21 (12), 3377-3388. doi: 10.1093/ndt/gfl543

Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines

2006

Journal Article

Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients

Armstrong, Kirsten, Rakhit, Dhrubo, Jeffriess, Leanne, Johnson, David, Leano, Rodel, Prins, John, Garske, Luke, Marwick, Thomas and Isbel, Nicole (2006). Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients. Clinical Journal of The American Society of Nephrology, 1 (6), 1275-1283. doi: 10.2215/CJN.00210106

Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients

2006

Journal Article

A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patients

Johnson, David W., Wong, Jennifer, Wiggins, Kathryn J., Kirwan, Robyn, Griffin, Anthony, Preston, John, Wall, Daryl, Campbell, Scott B., Isbel, Nicole M., Mudge, David W., Hawley, Carmel M. and Nicol, David L. (2006). A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patients. American Journal of Kidney Diseases, 48 (5), 812-821. doi: 10.1053/j.ajkd.2006.08.010

A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patients

2006

Journal Article

Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis

Teigen, Mette Maja B., Duffull, Stephen, Dang, Lily and Johnson, David W. (2006). Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. Journal of Clinical Pharmacology, 46 (11), 1259-1267. doi: 10.1177/0091270006292987

Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis

2006

Journal Article

Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease

Rakhit, D. J., Marwick, T. H., Armstrong, K. A., Johnson, D. W., Leano, R. and Isbel, N. M. (2006). Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart, 92 (10), 1402-1408. doi: 10.1136/hrt.2005.074393

Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease

2006

Journal Article

Novel renoprotective actions of erythropoietin: New uses for an old hormone

Johnson, David W., Forman, Colin and Vesey, David A. (2006). Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology, 11 (4), 306-312. doi: 10.1111/j.1440-1797.2006.00585.x

Novel renoprotective actions of erythropoietin: New uses for an old hormone

2006

Journal Article

Przewlekła choroba nerek: Uaktualnienie postępowania

Johnson, David W. and Usherwood, Tim (2006). Przewlekła choroba nerek: Uaktualnienie postępowania. Lekarz Rodzinny (7-8 (107-108)), 802-810.

Przewlekła choroba nerek: Uaktualnienie postępowania

2006

Journal Article

A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis Patients

Kaisar, Mohammed O., Wiggins, Kathryn J., Sturtevant, Joanne M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Mudge, David W., Bofinger, Andrew, Petrie, James J.B. and Johnson, David W. (2006). A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis Patients. American Journal of Kidney Diseases, 47 (5), 809-814. doi: 10.1053/j.ajkd.2006.01.014

A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis Patients

2006

Journal Article

In reply

Mathew, Timothy H., Jones, Graham and Johnson, David (2006). In reply. Medical Journal of Australia, 184 (9), 476-477. doi: 10.5694/j.1326-5377.2006.tb00330.x

In reply